InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Browse the full record of transactions filed by Utter Christine Marie, Chief Financial Officer. Officer active across 1 companies, notably PTC Therapeutics, INC.. Aggregated, 6 filings have been published. Total volume traded: €182k. The latest transaction was disclosed on 1 February 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations6 total
€11,150313 shares@ €35.62180.0002% mcap12.2% of flow
Common Stock
SEC:0001179110-22-000841·
€11,150313 shares@ €35.62180.0002% mcap6.1% of flow
Common Stock
SEC:0001179110-22-000841:0·
€54,4391,428 shares@ €38.12250.0009% mcap59.8% of flow
Common Stock
SEC:0001104659-22-005976·
€54,4391,428 shares@ €38.12250.0009% mcap29.9% of flow
Common Stock
SEC:0001104659-22-005976:0·
€25,474747 shares@ €34.10230.0004% mcap28.0% of flow
Common Stock
SEC:0001179110-22-000401·
€25,474747 shares@ €34.10230.0004% mcap14.0% of flow
Common Stock
SEC:0001179110-22-000401:0·
6 of 6 declarations
About Utter Christine Marie
Christine Marie Utter is the Chief Financial Officer and Chief Administrative Officer at PTC Therapeutics, Inc. She oversees financial management and administrative operations of the company. Her role is essential in ensuring compliance and operational efficiency at PTC Therapeutics.
